Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: Evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention

Pharmaceutical Biology

Volumn 49, Issue 11, 2011, Pages 1128-1136

  Golechha, Mahaveer ^a   Bhatia, Jagriti ^a   Ojha, Shreesh ^a   Arya, Dharmveer Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cognitive deficit; Kainic acid; Oxidative stress

Indexed keywords

EMBLICA OFFICINALIS EXTRACT; GLUTATHIONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; EPILEPTIC STATE; LATENT PERIOD; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT;

ALCOHOLS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHYLLANTHUS EMBLICA; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; REACTION TIME; SOLVENTS; STATUS EPILEPTICUS; TIME FACTORS;

EUPHORBIACEAE; PHYLLANTHUS EMBLICA; RATTUS;

EID: 80054957078     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.571264     Document Type: Article

References (50)

1. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. (2001). Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett, 497, 1-5.
2. Bartfai T, Sanchez-Alavez M, Andell-Jonsson S, Schultzberg M, Vezzani A, Danielsson E, Conti B. (2007). Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma. Ann N Y Acad Sci, 1113, 173-177.
3. Bauer B, Hartz AM, Pekcec A, Toellner K, Miller DS, Potschka H. (2008). Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol, 73, 1444-1453.
4. Becker A, Grecksch G, Brosz M. (1995). Antiepileptic drugs-their effects on kindled seizures and kindling-induced learning impairments. Pharmacol Biochem Behav, 52, 453-459.
5. Bertram EH. (2009). Temporal lobe epilepsy: Where do the seizures really begin? Epilepsy Behav, 14 (Suppl 1), 32-37.
6. Biswas NR, Gupta SK, Das GK, Kumar N, Mongre PK, Haldar D, Beri S. (2001). Evaluation of Ophthacare eye drops-a herbal formulation in the management of various ophthalmic disorders. Phytother Res, 15, 618-620.
7. Carreño M, Donaire A, Sánchez-Carpintero R. (2008). Cognitive disorders associated with epilepsy: Diagnosis and treatment. Neurologist, 14, S26-S34.
8. Chandra RH, Veeresham C, Asres K. (2004). Effect of Emblica officinalis commercial formulation in type 2 diabetic patients. Indian J Pharma Sci, 66, 735-738.
9. Chang BS, Lowenstein DH. (2003). Epilepsy. N Engl J Med, 349, 1257-1266.
10. Chen J, Quan QY, Yang F, Wang Y, Wang JC, Zhao G, Jiang W. (2010). Effects of lamotrigine and topiramate on hippocampal neurogenesis in experimental temporal-lobe epilepsy. Brain Res, 1313, 270-282.
11. Cherlyee CWJ, Thomas PB. (1995). Status epilepticus. Neurol Clin, 13, 529-548.
12. Choi J, Koh S. (2008). Role of brain inflammation in epileptogenesis. Yonsei Med J, 49, 1-18.
13. Dong XX, Wang Y, Qin ZH. (2009). Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin, 30, 379-387.
14. Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys, 82, 70-77.
15. Forman HJ, Zhang H, Rinna A. (2009). Glutathione: Overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med, 30, 1-12.
16. Grecksch G, Becker A, Gadau C, Matthies H. (1991). Gangliosides improve a memory deficit in pentylenetetrazol-kindled rats. Pharmacol Biochem Behav, 39, 825-828.
17. Gupta YK, Briyal S. (2006). Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in rats. Eur Neuropsychopharmacol, 16, 85-91.
18. Gupta YK, Briyal S, Sharma M. (2009). Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J Physiol Pharmacol, 53, 39-46.
19. Hessen E, Lossius MI, Reinvang I, Gjerstad L. (2006). Predictors of neuropsychological impairment in seizure-free epilepsy patients. Epilepsia, 47, 1870-1878.
20. Homayoun H, Khavandgar S, Zarrindast MR. (2001). Effects of adenosine receptor agonists and antagonists on pentylenetetrazoleinduced amnesia. Eur J Pharmacol, 430, 289-294.
21. Jacob A, Pandey M, Kapoor S, Saroja R. (1988). Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr, 42, 939-944.
22. Kardos J. (1999). Recent advances in GABA research. Neurochem Int, 34, 353-358.
23. Khan KH, Khan KH. (2009). Roles of Emblica officinalis in medicine-a review. Bot Res Int, 2, 218-228.
24. Kim HY, Okubo T, Juneja LR, Yokozawa T. (2010). The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr, 103, 502-512.
25. Kirtikar KR, Basu BD. (1996). Indian Medicinal Plants. Dehradun, India: International Book Distributor.
26. Kumaran A, Karunakaran RJ. (2006). Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr, 61, 1-5.
27. Lee JK, Won JS, Singh AK, Singh I. (2008). Statin inhibits kainic acidinduced seizure and associated inflammation and hippocampal cell death. Neurosci Lett, 440, 260-264.
28. Minghetti L. (2007). Role of COX-2 in inflammatory and degenerative brain diseases. Subcell Biochem, 42, 127-141.
29. Mohamad A, Mikati MA, Tarif S, Lteif L, Jawad MA. (2001). Time sequence and types of memory deficits after experimental status epilepticus. Epilepsy Res, 43, 97-101.
30. Montgomery EM, Bardgett ME, Lall B, Csernansky CA, Csernansky JG. (1999). Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Res Dev Brain Res, 112, 107-116.
31. Obay BD, Tasdemir E, Tümer C, Bilgin HM, Atmaca M. (2008). Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides, 29, 448-455.
32. Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-358.
33. Pozharitskaya ON, Ivanova SA, Shikov AN, Makarov VG. (2007). Separation and evaluation of free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH*method. J Sep Sci, 30, 1250-1254.
34. Pramyothin P, Samosorn P, Poungshompoo S, Chaichantipyuth C. (2006). The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury. J Ethnopharmacol, 107, 361-364.
35. Rao RS, Prakash A, Medhi B. (2009). Role of different cytokines and seizure susceptibility: A new dimension towards epilepsy research. Indian J Exp Biol, 47, 625-634.
36. Said SI, Pakbaz H, Berisha HI, Raza S. (2000). NMDA receptor activation: Critical role in oxidant tissue injury. Free Radic Biol Med, 28, 1300-1302.
37. Saito K, Kohno M, Yoshizaki F, Niwano Y. (2008). Extensive screening for edible herbal extracts with potent scavenging activity against superoxide anions. Plant Foods Hum Nutr, 63, 65-70.
38. Schmidt MJ, Ryan JJ, Molloy BB. (1976). Effects of kainic acid, a cyclic analogue of glutamic acid, on cyclic nucleotide accumulation in slices of rat cerebellum. Brain Res, 112, 113-126.
39. Schwarzer C, Sperk G. (1995). Hippocampal granule cells express glutamic acid decarboxylase-67 after limbic seizures in the rat. Neuroscience, 69, 705-709.
40. Sharma A, Sharma MK, Kumar M. (2009). Modulatory role of Emblica officinalis fruit extract against arsenic induced oxidative stress in Swiss albino mice. Chem Biol Interact, 180, 20-30.
41. Sierra-Paredes G, Sierra-Marcuño G. (2007). Extrasynaptic GABA and glutamate receptors in epilepsy. CNS Neurol Disord Drug Targets, 6, 288-300.
42. Silva B, Oliveira PJ, Dias A, Malva JO. (2008). Quercetin, kaempferol and biapigenin from Hypericum perforatum are neuroprotective against excitotoxic insults. Neurotox Res, 13, 265-279.
43. Stubley-Weatherly L, Harding JW, Wright JW. (1996). Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats. Brain Res, 716, 29-38.
44. Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S. (2003). COX-2 and neurodegeneration in Parkinsons disease. Ann N Y Acad Sci, 991, 272-277.
45. Ueda Y, Yokoyama H, Nakajima A, Tokumaru J, Doi T, Mitsuyama Y. (2002). Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus. Exp Brain Res, 147, 219-226.
46. Vezzani A, Granata T. (2005). Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia, 46, 1724-1743.
47. Vincent P, Mulle C. (2009). Kainate receptors in epilepsy and excitotoxicity. Neuroscience, 158, 309-323.
48. Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang L. (2009). Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res, 34, 1393-1400.
49. Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu DC, Juneja LR. (2007). Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr, 97, 1187-1195.
50. Zaja-Milatovic S, Gupta RC, Aschner M, Montine TJ, Milatovic D. (2008). Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicology, 29, 621-627.